Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study
Objective:. Residual cardiovascular risk in patients with coronary heart disease (CHD) still needs to be addressed in real-world practice. This study aimed to examine the clinical effectiveness of nicorandil and nitrate in addition to optimal treatment for CHD patients. Methods:. This retrospective...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-09-01
|
| Series: | Cardiology Discovery |
| Online Access: | http://journals.lww.com/10.1097/CD9.0000000000000092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849701475729539072 |
|---|---|
| author | Ping Li Juan Chen Na Li Xiang You Lan Shen Ning Zhou |
| author_facet | Ping Li Juan Chen Na Li Xiang You Lan Shen Ning Zhou |
| author_sort | Ping Li |
| collection | DOAJ |
| description | Objective:. Residual cardiovascular risk in patients with coronary heart disease (CHD) still needs to be addressed in real-world practice. This study aimed to examine the clinical effectiveness of nicorandil and nitrate in addition to optimal treatment for CHD patients.
Methods:. This retrospective cohort study included patients with CHD between October 2009 and March 2020 from 2 tertiary hospitals in Wuhan, China. Patients were grouped into nicorandil and nitrate groups depending on the first recorded antianginal therapy. Demographic and clinical data were collected from databases of the 2 hospitals. The primary outcome was cumulative 18-month major adverse cardiovascular event (MACE)-free survival, which was evaluated by Kaplan-Meier analysis. Propensity score matching (PSM) and multivariate Cox regression were adopted to adjust for confounding factors.
Results:. A total of 14,275 patients were analyzed, including 590 and 13,685 patients in the nicorandil and nitrate groups, respectively. With a median follow-up of 0.88 (Q1, Q3: 0.21, 1.54) years, the cumulative 18-month MACE-free survival rates were comparable between the 2 groups (80.0% vs. 75.0%, adjusted hazard ratio (aHR): 1.04, 95% confidence interval (CI): 0.42–2.56, P = 0.982,7) after 1:4 PSM. The cumulative 18-month stroke-free survival rate was significantly higher in the nicorandil group compared to the nitrate group (93.0% vs. 84.0%, aHR: 0.56, 95% CI: 0.34–0.92, P = 0.023,5).
Conclusion:. This retrospective study showed that nicorandil and nitrate have similar 18-month rates of MACEs in CHD patients, but nicorandil is associated with lower incidence of stroke compared to nitrate. More studies need to be conducted to validate this association and explore the long-term benefit of nicorandil use on the occurrence of MACEs in the future. |
| format | Article |
| id | doaj-art-db88191c05e1403e94f97cf9c33a15bd |
| institution | DOAJ |
| issn | 2096-952X 2693-8499 |
| language | English |
| publishDate | 2023-09-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Cardiology Discovery |
| spelling | doaj-art-db88191c05e1403e94f97cf9c33a15bd2025-08-20T03:17:55ZengWolters Kluwer Health/LWWCardiology Discovery2096-952X2693-84992023-09-013315215810.1097/CD9.0000000000000092202309000-00002Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort StudyPing Li0Juan Chen1Na Li2Xiang You3Lan Shen4Ning Zhou51 Department of Cardiothoracic Surgery, Union Hospital of Huazhong University of Science and Technology, Wuhan, Hubei 430022, China2 Department of Cardiology, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei 430014, China3 Division of Cardiology, Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei 430030, China4 Chugai Pharma China Co., Ltd., Shanghai 200020, China5 Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200025, China.3 Division of Cardiology, Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei 430030, ChinaObjective:. Residual cardiovascular risk in patients with coronary heart disease (CHD) still needs to be addressed in real-world practice. This study aimed to examine the clinical effectiveness of nicorandil and nitrate in addition to optimal treatment for CHD patients. Methods:. This retrospective cohort study included patients with CHD between October 2009 and March 2020 from 2 tertiary hospitals in Wuhan, China. Patients were grouped into nicorandil and nitrate groups depending on the first recorded antianginal therapy. Demographic and clinical data were collected from databases of the 2 hospitals. The primary outcome was cumulative 18-month major adverse cardiovascular event (MACE)-free survival, which was evaluated by Kaplan-Meier analysis. Propensity score matching (PSM) and multivariate Cox regression were adopted to adjust for confounding factors. Results:. A total of 14,275 patients were analyzed, including 590 and 13,685 patients in the nicorandil and nitrate groups, respectively. With a median follow-up of 0.88 (Q1, Q3: 0.21, 1.54) years, the cumulative 18-month MACE-free survival rates were comparable between the 2 groups (80.0% vs. 75.0%, adjusted hazard ratio (aHR): 1.04, 95% confidence interval (CI): 0.42–2.56, P = 0.982,7) after 1:4 PSM. The cumulative 18-month stroke-free survival rate was significantly higher in the nicorandil group compared to the nitrate group (93.0% vs. 84.0%, aHR: 0.56, 95% CI: 0.34–0.92, P = 0.023,5). Conclusion:. This retrospective study showed that nicorandil and nitrate have similar 18-month rates of MACEs in CHD patients, but nicorandil is associated with lower incidence of stroke compared to nitrate. More studies need to be conducted to validate this association and explore the long-term benefit of nicorandil use on the occurrence of MACEs in the future.http://journals.lww.com/10.1097/CD9.0000000000000092 |
| spellingShingle | Ping Li Juan Chen Na Li Xiang You Lan Shen Ning Zhou Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study Cardiology Discovery |
| title | Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study |
| title_full | Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study |
| title_fullStr | Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study |
| title_full_unstemmed | Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study |
| title_short | Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study |
| title_sort | real world major adverse cardiovascular events of nicorandil and nitrate in coronary heart disease in central china a retrospective cohort study |
| url | http://journals.lww.com/10.1097/CD9.0000000000000092 |
| work_keys_str_mv | AT pingli realworldmajoradversecardiovasculareventsofnicorandilandnitrateincoronaryheartdiseaseincentralchinaaretrospectivecohortstudy AT juanchen realworldmajoradversecardiovasculareventsofnicorandilandnitrateincoronaryheartdiseaseincentralchinaaretrospectivecohortstudy AT nali realworldmajoradversecardiovasculareventsofnicorandilandnitrateincoronaryheartdiseaseincentralchinaaretrospectivecohortstudy AT xiangyou realworldmajoradversecardiovasculareventsofnicorandilandnitrateincoronaryheartdiseaseincentralchinaaretrospectivecohortstudy AT lanshen realworldmajoradversecardiovasculareventsofnicorandilandnitrateincoronaryheartdiseaseincentralchinaaretrospectivecohortstudy AT ningzhou realworldmajoradversecardiovasculareventsofnicorandilandnitrateincoronaryheartdiseaseincentralchinaaretrospectivecohortstudy |